Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 2, 2004, Pages 279-283

  Fu, Xiao Hui ^a   Tang, Zhao Hui ^a   Zong, Ming ^a   Yang, Guang Shun ^a   Yao, Xiao Ping ^a   Wu, Meng Chao ^a  

^a EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

Intrahepatic cholangiocarcinoma; Pathology; Surgery

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCITES; BILE DUCT CARCINOMA; CANCER INVASION; CANCER STAGING; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SEX DIFFERENCE; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT SURGICAL PROCEDURES; CHOLANGIOCARCINOMA; CLINICAL PROTOCOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2442674133     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The Liver Study Group of Japan. Primary liver cancer in Japan: Sixth report. Cancer 1987;60:1400-1411.
2. Tang ZY. Small hepatocellular carcinoma: current status and prospects. Hepatobiliary Pancreat Dis Int 2002;1:349-353.
3. Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology 2003;37:961-969.
4. Martin R, Jarnagin W. Intrahepatic cholangiocarcinoma: Current management. Minerva Chir 2003;58:469-478.
5. Kawarada Y, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg 1984;147:354-359.
6. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-88.
7. Chu KM, Fan ST. Intrahepatic cholangiocarcinoma in Hong Kong. J Hepatobiliary Pancreat Surg 1999;6:149-153.
8. Kim HJ, Yun SS, Jung KH, Kwun WH, Choi JH. Intrahepatic cholangiocarcinoma in Korea. J Hepatobiliary Pancreat Surg 1999;6:142-148.
9. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J. Resection of intrahepatic cholangiocarcinoma: a western experience. J Hepatobiliary Pancreat Surg 1999;6:122-127.
10. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-fortrung intrahepatic cholangiocarcinoma. World J Surg 2002;26:687-693.
11. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002; 183:679-685.
12. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 2004;239:202-209.
13. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001;12: 959-964.
14. Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998;4:392-396.
15. Curley SA. Diagnosis and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer Treat Res 2001;109: 117-144.
16. Choi BI, Han JK, Shin YM, Back SY, Han MC. Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging 1995;20:357-360.
17. Fulcher AS, Sterling RK. Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002;34:463-471.
18. Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002;131: S159-164.
19. Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002;49:326-329.
20. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 1997;44:760-765.
21. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001 193:384-391.
22. Tsuji T, Hiraoka T, Kanemitsu K, Takamori H, Tanabe D, Tashiro S. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 2001;129:401-407.
23. Yamamoto M, Takasaki K, Yoshikawa T. Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:117-121.
24. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69: 1633-1637.
25. Shimada M, Takenaka K, Kawahara N, Yamamoto K, Shirabe K, Maehara Y, et al. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathologial factors. Hepatogastroenterology 1996;43: 1159-1164.
26. Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Hubeman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998;82:2321-2325.
27. Verderme F, Mandina P, Abruzzo F, Scarpulla M, Di Leo R. Biliary tract cancer: our experience with gemcitabine treatment. Anticaner Drugs 2000;11:707-708.
28. Aishima SI, Taguchi KI, Sugimachi K, Shimada M, Sugimachi K, Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Histopathology 2002;40:269-278.
29. Fiorentino M, Altimari A, D'Errico A, Gabusi E, Chieco P, Masetri M, et al. Low p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinoma. Clin Cancer Res 2001;7:3994-3999.
30. Chariyalertsak S, Sirikulchayanonta V, Mayer D, Kopp-Schneider A, Furstenberger G, Marks F, et al. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut 2001;48:80-86.
31. Harada K, Zen Y, Kanemori Y, Chen TC, Chen MF, Yeh TS, et al. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions. Hepatology 2001 33:1036-1042.